1-(5-hydroxy-1,5-dimethylhexyl)-3-{7-[3-(pyridin-3-ylmethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}urea

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 1-(5-hydroxy-1,5-dimethylhexyl)-3-{7-[3-(pyridin-3-ylmethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}urea
• 英文别名: 1-(6-Hydroxy-6-methylheptan-2-yl)-3-[7-[3-(pyridin-3-ylmethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea
• 化学式: C₂₆H₃₁N₇O₃
• 分子量: 489.577
• InChiKey: PEOJHGPSITVMEP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  36
• 可旋转键数：
  10
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  127
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  6-氨基-2-甲基-2-庚醇 、 以 1,3-二甲基-2-咪唑啉酮 为溶剂， 生成 1-(5-hydroxy-1,5-dimethylhexyl)-3-{7-[3-(pyridin-3-ylmethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}urea
  参考文献：
  名称：

  [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF

  摘要：

  公开号：

  EP1630165B1

文献信息

• [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof
  申请人：Masuda Akira

  公开号：US20070010515A1

  公开（公告）日：2007-01-11

  Novel [1,2,4]triazolo[1,5-a]pyrimidine derivative of the general formula (1): (1) its prodrug or a pharmaceutically acceptable salt thereof, which exhibits an antigen presentation inhibiting activity and is useful as a preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease and also useful as an anticancer drug or as an immunological tolerance inducer for transplanted organ/transplanted bone marrow.

  这是一种通式为(1)的[1,2,4]三唑并[1,5-a]嘧啶衍生物的小说，其中(1)是其前药或其药学上可接受的盐，具有抗原呈递抑制活性，可用作预防和/或治疗器官/骨髓移植、自身免疫性疾病、过敏性疾病和/或炎症性疾病的免疫排斥和/或移植物抗宿主反应的预防和/或治疗剂，同时也可用作抗癌药物或用于移植器官/移植骨髓的免疫耐受诱导剂。
• [1,2,4 ]TRIAZOLO [1,5-A]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
  申请人：NIPPON KAYAKU KABUSHIKI KAISHA

  公开号：EP1630165A1

  公开（公告）日：2006-03-01

  Novel [1,2,4]triazolo[1,5-a]pyrimidine derivative of the general formula (1): (1) its prodrug or a pharmaceutically acceptable salt thereof, which exhibits an antigen presentation inhibiting activity and is useful as a preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease and also useful as an anticancer drug or as an immunological tolerance inducer for transplanted organ/transplanted bone marrow.

  通式（1）的新型[1,2,4]三唑并[1,5-a]嘧啶衍生物：(1) 其原药或其药学上可接受的盐，具有抗原递呈抑制活性，可作为器官/骨髓移植、自身免疫性疾病、过敏性疾病和/或炎症性疾病中免疫排斥和/或移植物与宿主反应的预防和/或治疗药物，也可作为抗癌药物或移植器官/移植骨髓的免疫耐受诱导剂。
• METHOD FOR PRODUCING REGULATORY DENDRITIC CELLS
  申请人：Nippon Kayaku Kabushiki Kaisha

  公开号：EP2540821A1

  公开（公告）日：2013-01-02

  An object of the present invention is to establish a method that enables safe and convenient large-scale preparation of regulatory dendritic cells. The present invention provides a method for preparing regulatory dendritic cells, which comprises culturing cells that can be induced to result in regulatory dendritic cells in the presence of a [1,2,4]triazolo[1,5-a]pyrimidine derivative.

  本发明的目的是建立一种能够安全方便地大规模制备调节性树突状细胞的方法。本发明提供了一种制备调节性树突状细胞的方法，该方法包括在[1,2,4]三唑并[1,5-a]嘧啶衍生物存在下培养可诱导形成调节性树突状细胞的细胞。
• METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
  申请人：Todo Satoru

  公开号：US20130052734A1

  公开（公告）日：2013-02-28

  An object of the present invention is to establish a method that enables safe and convenient large-scale preparation of regulatory dendritic cells. The present invention provides a method for preparing regulatory dendritic cells, which comprises culturing cells that can be induced to result in regulatory dendritic cells in the presence of a [1,2,4]triazolo[1,5-a]pyrimidine derivative.
• US7598244B2
  申请人：——

  公开号：US7598244B2

  公开（公告）日：2009-10-06